A new study found that women who test positive for A Parkinson-s related protein accumulated tau at a much faster rate, ...

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

A growing body of research points to chronic, low-grade inflammation inside the brain as a possible accelerant of Alzheimer’s disease, not just a bystander response to damage already done. The 2024 ...

There’s growing evidence that people can take steps to keep their brains healthy and reduce the risk of dementia.

Persistent inflammation in the gut, lungs and skin might lead to Alzheimer's disease, but lifestyle choices - from getting ...

By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment candidate at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026 in ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Doctors break it down.

Two new clinical trials aimed at treating Alzheimer’s disease are starting up at Barrow Neurological Institute.

WPI researchers use machine learning and brain scans to identify age- and sex-specific anatomical patterns that predict ...

The Alzheimer’s Foundation of America is hosting the ‘Alzheimer’s and Caregiving Educational Conference,’ giving you a chance ...

Advocacy Day at the State House allows groups across South Carolina the chance to meet with lawmakers -- and make change.